141 related articles for article (PubMed ID: 34805843)
1. Diffusion-weighted imaging and variable flip angle T1 mapping: a supplement for image-guided biopsy in follow-up analysis of liver fibrosis.
Hu P; Sun J; Lv F; Pi B; Xu F; Han G; Hu X; Wang Y; Huang N; Wu X; Yang X
J Interv Med; 2018 Aug; 1(3):150-156. PubMed ID: 34805843
[No Abstract] [Full Text] [Related]
2. Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T.
Li Z; Sun J; Hu X; Huang N; Han G; Chen L; Zhou Y; Bai W; Yang X
J Magn Reson Imaging; 2016 Mar; 43(3):698-703. PubMed ID: 26267123
[TBL] [Abstract][Full Text] [Related]
3. Assessment of liver fibrosis in rats by MRI with apparent diffusion coefficient and T1 relaxation time in the rotating frame.
Hu G; Zhang X; Liang W; Zhong X; Chan Q; Lin X; Lin T; Li Y; Quan X
J Magn Reson Imaging; 2016 May; 43(5):1082-9. PubMed ID: 26497954
[TBL] [Abstract][Full Text] [Related]
4. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis.
Kromrey ML; Le Bihan D; Ichikawa S; Motosugi U
Radiology; 2020 Apr; 295(1):127-135. PubMed ID: 32043948
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effect of region-of-interest methods using gadoxetic acid-enhanced MR imaging with diffusion-weighted imaging on staging hepatic fibrosis.
Ding Y; Rao S; Yang L; Chen C; Zeng M
Radiol Med; 2016 Nov; 121(11):821-827. PubMed ID: 27449761
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J
Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach.
Feier D; Balassy C; Bastati N; Fragner R; Wrba F; Ba-Ssalamah A
Eur Radiol; 2016 Feb; 26(2):539-46. PubMed ID: 25991488
[TBL] [Abstract][Full Text] [Related]
9. The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease.
Tokgöz Ö; Unal I; Turgut GG; Yildiz S
Acta Clin Belg; 2014 Dec; 69(6):426-32. PubMed ID: 25103596
[TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging.
Ding Y; Rao SX; Zhu T; Chen CZ; Li RC; Zeng MS
Clin Radiol; 2015 Oct; 70(10):1096-103. PubMed ID: 26164421
[TBL] [Abstract][Full Text] [Related]
11. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver.
Okada M; Murakami T; Yada N; Numata K; Onoda M; Hyodo T; Inoue T; Ishii K; Kudo M
J Magn Reson Imaging; 2015 Feb; 41(2):329-38. PubMed ID: 24343840
[TBL] [Abstract][Full Text] [Related]
12. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
[TBL] [Abstract][Full Text] [Related]
13. Diffusion kurtosis imaging with the breath-hold technique for staging hepatic fibrosis: A preliminary study.
Yoshimaru D; Miyati T; Suzuki Y; Hamada Y; Mogi N; Funaki A; Tabata A; Masunaga A; Shimada M; Tobari M; Nishino T
Magn Reson Imaging; 2018 Apr; 47():33-38. PubMed ID: 29158186
[TBL] [Abstract][Full Text] [Related]
14. Relative ADC measurement for liver fibrosis diagnosis in chronic hepatitis B using spleen/renal cortex as the reference organs at 3 T.
Hong Y; Shi Y; Liao W; Klahr NJ; Xia F; Xu C; Li Y; Guo Q
Clin Radiol; 2014 Jun; 69(6):581-8. PubMed ID: 24581967
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Pancreatic Fibrosis Grading by Multiparametric Quantitative Magnetic Resonance Imaging.
Liu C; Shi Y; Lan G; Xu Y; Yang F
J Magn Reson Imaging; 2021 Nov; 54(5):1417-1429. PubMed ID: 33819364
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].
Zhou ML; Yan FH; Xu PJ; Chen CZ; Shen JZ; Li RC; Ji Y; Shi JY
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1757-61. PubMed ID: 19862980
[TBL] [Abstract][Full Text] [Related]
17. Comparison of T2, T1rho, and diffusion metrics in assessment of liver fibrosis in rats.
Zhang H; Yang Q; Yu T; Chen X; Huang J; Tan C; Liang B; Guo H
J Magn Reson Imaging; 2017 Mar; 45(3):741-750. PubMed ID: 27527587
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus.
Besheer T; Elalfy H; Abd El-Maksoud M; Abd El-Razek A; Taman S; Zalata K; Elkashef W; Zaghloul H; Elshahawy H; Raafat D; Elemshaty W; Elsayed E; El-Gilany AH; El-Bendary M
World J Gastroenterol; 2019 Mar; 25(11):1366-1377. PubMed ID: 30918429
[TBL] [Abstract][Full Text] [Related]
19. Assessment of dynamic hepatic and renal imaging changes in COVID-19 survivors using T1 mapping and IVIM-DWI.
Han Q; Lu Y; Wang D; Zhao Y; Li X; Mei N; Zhu Y; Xiao A; Yin B
Abdom Radiol (NY); 2022 May; 47(5):1817-1827. PubMed ID: 35279759
[TBL] [Abstract][Full Text] [Related]
20. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
Ding Y; Rao SX; Chen C; Li R; Zeng MS
Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
